Trials / Completed
CompletedNCT01248650
Safety Study of TRK-820 for Patient With Hemodialysis
A Clinical Study to Investigate Pharmacokinetics and Safety of Single-Dose TRK-820 Soft Capsule in Patient With Hemodialysis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe pharmacokinetics and safety of nalfurafine hydrochloride in patients receiving hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nalfurafine hydrochloride |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2010-11-25
- Last updated
- 2010-11-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01248650. Inclusion in this directory is not an endorsement.